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Age-related hearing loss, known as presbyacusis, is characterized by the progressive deterioration of auditory sensitivity
associated with the aging process and is the leading cause of adult auditory deficiency in the USA. Presbyacusis is described
as a progressive, bilateral, high-frequency hearing loss that is manifested on audiometric assessment by a moderately sloping
pure tone audiogram. Approximately 23% of the population between 65 and 75 years of age, and 40% of the population
older than 75 years of age are affected by this condition. It was estimated in 1980 that 11% of the population was 76 years or
older and this number is expected to almost double by the year 2030. When one considers that the population over 65 years
of age is experiencing the most accelerated development of hearing loss, the potential socioeconomic ramifications are
staggering. Curiously, the frequency of presbyacusis varies across different societies. This discrepancy has been attributed to
many factors including genetics, diet, socioeconomic factors, and environmental variables. The purpose of this article is to
review the various molecular mechanisms underlying presbyacusis and to offer insights into potential methods of mitigating
the effects of aging on hearing impairment Key words: aging, mitochondrial DNA mutations, presbyacusis, reactive oxygen
species.
INTRODUCTION
Aging is associated with a wide array of physiological,
biochemical, and molecular changes including pro-
gressive DNA damage, deterioration of mitochondrial
function, reduction of cellular water concentrations,
ionic changes, vascular insufficiency, and decreased
elasticity of cellular membranes. Studies have pro-
posed that many factors contribute to this process,
such as: altered vascular characteristics; reduced red
blood cell velocity and vascular plasticity; increased
vascular permeability (1, 2); reductions in oxygen and
nutrient delivery and waste elimination (3/6); genetic
mutations; and a significant presence of reactive
oxygen species (ROS), otherwise known as free
radicals. Concurrent with the increase in ROS is a
decreased production or function of the endogenous
enzymes that protect the cell against ROS damage
including superoxide dismutase, catalase and glu-
tathione peroxidase. These ROS have been shown to
contribute in part to producing mitochondrial DNA
(mtDNA) damage by causing deletions in the mito-
chondrial genome. These deletions are an important
component of the age-associated diminution in audi-
tory sensitivity. Specific deletions are known to be
directly proportional to aging such as the common
aging deletion in humans, which is 4977 base pairs in
length (4834 base pairs in rats). When mtDNA
deletions reach a certain level, the mitochondria
become bioenergetically inefficient. This inefficiency
can be measured through reductions in specific
enzymes (cytochrome oxidase (COX), succinate dehy-
drogenase (SDH), nicotinamide adenine dinucleotide
(NADH)), as well as by using flow cytometry to
measure reductions in mitochondrial membrane
potentials (MMP) (Fig. 1), which serves as a marker
of mitochondrial function, and by the measurement of
specific deletions or point mutations in the mitochon-
drial DNA genome. Fig. 1A and 1B are typical
histograms of cell fluorescence in young and old rat
lymphocytes (106) incubated with 0.5 nM DiOC6.
Preliminary results revealed a two- to threefold greater
intensity of DiOC6 staining of peripheral blood
lymphocytes (PBL) of young compared with old rats
(Fig. 1C). Reductions in mitochondrial function and
increases in mtDNA deletions have been identified
within heart, brain, liver and skeletal muscle samples
in aged rats, mice, monkeys and humans
(7/11).
Aging thus involves the growing accumulation of
metabolic and physiologic changes associated with an
increasing susceptibility to disease. There are four
main sources for failure of biological systems that may
in part contribute to the aging processes.
1. Gene repression: essentially, this is a systematic,
and probably programmed, age-dependent gene
deterioration. Semsei et al. have demonstrated
that increased intracellular potassium results in
chromatin condensation with a consequent decline
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in RNA synthesis (12). This general decline in
protein synthesis may in part account for the age-
dependent decrease in gene expression, leading to
the turning off of specific biological systems.
Hence, a threshold exists beyond which home-
ostasis begins to fail.
2. Intracellular communication: this is based upon the
fact that cells require specific spatial arrangement
which provides for the rapid transfer of molecules
to neighboring cells. Any change in this spatial
arrangement may lead to breakdown in cellular
communication with resultant tissue aging, disease
and death. It is known that mutations in connexin-
26, a gap junction protein, are responsible for a
major form of non-syndromic recessive deafness
and a more limited form of non-syndromic domi-
nant hearing loss (13). It is possible that a similar
mechanism may be involved in age-related hearing
loss.
3. Waste accumulation: over time there are significant
increases in waste products. The ability of cells to
handle and process these products progressively
decreases, hence, an increase in accretional defects,
i.e. intima thickening, lipofuscin accumulation, and
damaged collagen.
4. Age-related depletional defects: over time there is
progressive breakdown of cellular function. When
this accumulates with age, entire organ systems lose
their normal function, often leading to disease
states as well as normal physiologic aging (14).
There are many hypotheses in the current literature
providing explanations for senescence. Three of the
most convincing theories are the telomerase theory of
aging, the dysdifferentiation hypothesis of aging and
the membrane hypothesis of aging (MHA; also
referred to as the ‘mitochondrial clock theory’ of
aging).
The telomerase theory of aging suggests that there is
a reduction in telomere length over time. The end of a
chromosome is made up of a structure called the
telosome. The tip of the telosome is a region of DNA
repeat sequences and associated proteins collectively
known as the telomere. It is hypothesized that DNA
transcription and replication are affected by position
effects mediated by the telomere. Reduction in the
length of the telomere and alterations in its chromatin
assembly may explain the instability that occurs
during senescence as well as the immortalization
process in vitro (15). In tumor-derived cell lines,
telomeres are maintained by the ribonucleoprotein
enzyme, telomerase. However, telomerase activity is
repressed in practically all normal human somatic
cells. Thus, there is an inherent problem of end-
replication creating a tendency toward progressive
telomere shortening. Cumulatively, this predilection
leads to limited replicative capacity, chromatin in-
stability and eventually, cellular senescence. Viral
oncogenes or certain somatic mutations can block
cellular aging probably by activating telomerase.
Telomere shortening is therefore effectively prevented
and this appears to be an important mechanism for
sustaining the cellular growth of tumors (16). Low-
level telomerase activity has also been demonstrated in
normal human T and B cells, which was also shown to
decrease with aging (17). Although many aspects of
telomerase activity remain undefined, it has been
hypothesized that the balance between telomere short-
ening and telomerase activity may underlie cellular
aging processes. Therefore, although unproven,
changes in telomeres may also predispose to the
development of presbyacusis.
The dysdifferentiation theory suggests that aging is
a continuum of programmed differentiation leading to
either a cessation of normal gene activity or a
systematic activation of genes whose effects are
deleterious to cellular function. Support for this
Fig. 1. Mitochondrial membrane potential (MMP) was
studied by flow cytometry. 3,3?-Dihexyloxacarbocyanine
(DiOC6), which is used for the quantitative measurement
of MMP, is a lipophilic, cationic, fluorescent probe. Periph-
eral blood lymphocytes (PBL) of young (6 months) and old
(24 months) (106) rats were equilibrated with very low
concentrations (0.5 nM) of DiOC6. (A) and (B) Typical
histograms of cell fluorescence in young and old rat
lymphocytes (106) incubated with 0.5 nM DiOC6. There is
a two- to threefold greater intensity of DiOC6 staining of
PBL of young compared with old rats (C). The mean
fluorescence of cells treated with and without carbonyl
cyanide m-chlorophenylhydrazone (CCCP) (20 mM) is
shown in (C). Cells treated with CCCP consisted of low
fluorescence, about 30% of control.
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theory is provided by apoptosis (programmed cell
death) studies in Caenorhabditis elegans (C. elegans )
(earthworm). These experiments elegantly elaborated
the genetic mechanisms responsible for controlling cell
death. The maintenance of homeostasis for cellular
metabolism and function consumes a large fraction of
total body energy expenditure. This is engineered by
the delicate balance between cellular proliferation and
death. The Bcl-2 gene, for example, exists in progeni-
tor and long-lived cells and therefore appears to have a
key function in the cells of the developing embryo. The
gene appears to prevent oxidative damage to cellular
organelles and lipid membranes. Studies have demon-
strated that Bcl-2 protects cells from the toxicity of
H2O2 or t-butyl hydroperoxide in a dose-dependent
manner (18, 19). Bcl-2 -deficient mice demonstrate
changes expected of more rapid cell death, including
fulminant lymphoid apoptosis of systemic organs (20).
Bcl-2 also inhibits other types of apoptotic cell death,
implying a common mechanism of lethality. Studies
have demonstrated, for example, that Bcl-2 protected
cells from H2O2 and menadione-induced oxidative
deaths (18, 21). Another protein that appears to
operate as an accessory to Bcl-2 , is a 21 kd protein
referred to as Bax . In experiments by Hockenberry
and colleagues, the suggested model of the ratio
between Bcl-2 and Bax appears to determine survival
or death following an apoptotic stimulus. Specifically,
elevated expression of Bcl-2 appears to be preventa-
tive, while that of Bax favors the apoptotic process.
Lastly, the membrane hypothesis of aging states that
aging is related to decreasing effectiveness of cellular
protective and reparative mechanisms. This yields
biochemical and metabolic errors, which progressively
accumulate resulting in cell death (22). The membrane
hypothesis of aging (MHA) further postulates that
cellular senescence is attributable to the cross-linking
action of free oxygen radicals within the cellular
membrane. Additionally, ROS lead to lipid peroxida-
tion, polysaccharide depolymerization, nucleic acid
disruption, and oxidation of sulfhydryl groups leading
to enzyme inactivation (23). Therefore, the MHA
suggests that ROS-induced cell membrane structural
damage is the primary mediator in cellular aging (24,
25).
Careful analysis of the above mechanisms suggests
that certain aspects of the three leading theories of
aging may be interrelated. That is, free radical species
lead to genetic and cellular alterations resulting in
cellular dysfunction, and consequently senescence, and
perhaps presbyacusis. It is even more intriguing to
realize that a trigger for the Bax gene are the ROS
(26). Thus, a critical analysis of the prominent
hypotheses of aging suggests that aspects of all three
theories are likely to apply. Specifically, the generation
of ROS damages cellular integrity, which may lead to
alterations in gene expression, including telomere
shortening and activation of Bax genes, resulting in
aging, presbyacusis and ultimately death.
As presbyacusis represents one aspect of aging, it is
imperative thus to understand these molecular me-
chanisms of aging. In our laboratory, studies have
focused on the mitochondrial theory of aging and its
applicability to presbyacusis. There are, however,
several animal models that have been used to study
presbyacusis. These models have served to illuminate
the various molecular mechanisms underlying age-
related hearing loss. One such model is the C57BL/6J
strain of mice, which demonstrates an age-dependent,
high-frequency, sloping loss (27). The adult hearing
loss (Ahl) gene, characterized as recessive and mapped
to chromosome 10, has been identified in the C57
mouse strain and is the presumed cause of progressive
hearing loss in this species. A proposed mechanism for
this progressive hearing loss is that the Ahl gene
mediates, through mRNA expression, a decrease in
protective enzymes and therefore an increase in levels
of oxidative stress within the period of time that the
C57 mouse strain undergoes increased exposure to free
radicals and its most significant diminution in hearing
(28). More recently, the Ahl gene has also been
implicated in noise-induced hearing loss (NIHL) (29).
In other studies, cochlear microphonic (CM) sensi-
tivity has been shown to vary with age, with a gradual
decrease in sensitivity from 12 to 24 months of age
(30). Rat cochlear action potential (CAP) sensitivity
has also been shown to decrease with age, and changes
in CAP waveform with age have been shown (31). In a
study of rat auditory brainstem response (ABR), delay
in conduction times and waveform amplitude de-
creases were noted to occur in older animals (32).
Our laboratory has studied groups of rats varying in
age and has documented evidence of presbyacusis
using changes in cochlear microcirculation, electro-
physiology, molecular biology and histology (33, 34).
Furthermore, histologic analysis of presbyacusis sub-
jects demonstrate age-related hair cell degeneration
and loss (35). Human studies reveal a preferential loss
of outer hair cells (OHCs) (36, 37). Loss of OHCs is
greatest in the first half of the basal turn (36, 38). This
correlates tonotopically with the high-frequency loss
seen in human presbyacusis. In the rat, age-related
hair cell loss is also predominantly OHC in nature. In
a study of elderly rats, inner hair cell (IHC) losses
ranged from 3.1% to 9.2%, while OHC losses ranged
from 7.4% to 46.8%. The IHC loss was greatest in the
upper apex while OHC losses were greatest at the basal
turn (39). While there are species-specific variations in
cochleotopic patterns of hair cell loss, the rat is an
appropriate aging model (30, 32, 39) (Fig. 2). Several
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human studies have also demonstrated accelerated
hearing loss in patients with Alzheimer’s disease and
other cognitive and neurodegenerative disorders
(40/42). There is a genetic predilection for Alzhei-
mer’s disease and perhaps these findings can be
extrapolated to auditory dysfunction as well. As the
formation of reactive oxygen species (ROS) and their
subsequent effects on mitochondrial integrity are an
integral mechanism in presbyacusis, it is important to
consider these processes in greater detail.
REACTIVE OXYGEN SPECIES (ROS)
Reactive oxygen species (ROS) contain an unpaired
number of electrons, making them chemically reactive
and extremely toxic to cellular and subcellular struc-
tures. ROS have been implicated in more than 100
clinical conditions (43). They are produced in vivo
during mitochondrial respiration, as well as via auto-
oxidation of chemical and biological molecules. ROS
are also environmental contaminants and can be
formed from ionizing and ultraviolet radiation. The
most common ROS are superoxide anion (O2
),
hydroxyl radical (OH), hypochloride (OCL) and
nitric oxide (NO). Not only is the pathogenic role of
ROS becoming acceptable in the realm of human
disease, but their contribution as active participants in
determining disease activity is also becoming increas-
ingly recognized (44). Despite this primacy, ROS are
notoriously difficult to quantify in biological systems.
However, the use of modern assay techniques has
made this less of a limitation (43).
There is extensive support in the literature for the
protective effects of antioxidants and ROS scavengers.
For example, tocopherols decrease the process of
atherosclerosis and delay death from myocardial
infarction, presumably by inhibiting lipid peroxidation
(45). Carotenoids, such as b-carotene and other plant
pigments, may also have preventive effects against
cancer and cardiovascular disease (45/47).
Available data also suggest that many of the
pathological correlates of Alzheimer’s disease are
precipitated by oxidative stress-induced mechanisms
(48/50). Similarly, Parkinson’s disease has also been
associated with oxidative stress, increased lipid perox-
idation, reduced levels of glutathione (GSH), high
concentrations of iron, and free radical generation via
auto-catalytic mechanisms within neuromelanin con-
taining catecholaminergic neurons (51, 52). Recent
studies have further demonstrated that aging in the
central nervous system is directly correlated with
oxidative stress. In the harlequin mouse model, muta-
tions in the apoptosis-inducing factor (AIF) gene
resulted in greater susceptibility to ROS-induced
damage (53). A lack or down-regulation of AIF in
neuronal cells renders them more sensitive to per-
oxides and to a much larger extent vulnerable to
progressive increases in ROS-induced damage. This
observation provides a molecular mechanism by which
free radical damage can lead to neuronal death.
Many intrinsic enzyme systems protect cells from
oxidative damage. These include superoxide dismutase
(SOD), glutathione peroxidase, and the glutathione
transferases, and catalase. Additionally, a variety of
small molecules in the human diet are required for
antioxidant defenses. Experimentally and clinically, it
is well known that a primary source of ROS generation
is through oxidative phosphorylation, ischemia/reper-
fusion or prolonged hypoperfusion, such as that seen
in myocardial infarction, cerebrovascular accidents,
Fig. 2. Photomicrograph (40/) of the
cochlea from a representative animal. It
shows a surface mount preparation of
the basillar membrane of the right organ
of Corti with osmium tetroxide staining
from a 4-month old (A) and an 18-
month old (B) rat. Outer hair cell rows
are shown by 1, 2, and 3. ‘I’ denotes the
single inner hair cell row. Loss of hair
cells is denoted by arrows. No obvious
hair cell pathology is noted in (A). Hair
cell loss is shown in (B).
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aging, and possibly sudden sensorineural hearing loss
and presbyacusis. It is clear that in the aging cochlea
there is a significant reduction of blood supply and the
ongoing need for energy generation through oxidative
phosphorylation (2). Thus, these two processes, as well
as others, allow for the generation of ROS within the
cochlea.
MITOCHONDRIAL DNA DELETIONS (MTDNA
DEL) AND HEARING LOSS
Mitochondria are unique organelles possessing their
own DNA as well as their own enzymatic constituents
to allow for transcription and translation of genetic
information into proteins. Each mtDNA codes for a
complete set of ribosomal (rRNA) and transfer RNA
(tRNA). Additionally, mtDNA codes for 13 of the
approximately 60 polypeptides necessary for oxidative
phosphorylation. These include seven of the 25 sub-
units of respiratory complex I (ND1-4, 4L, 5, and
6)(NADH-ubiquinol-oxidoreductase), one of the ap-
proximately nine subunits (cyt b) of respiratory
complex III (ubiquinol-cytochrome c oxidoreductase),
three of the 13 subunits of respiratory complex IV
(COI, COII, and COIII) (cytochrome c oxidase), and
two of the 12 subunits of respiratory complex V
(ATP6 and 8) (ATP synthase). The remaining subunits
of these complexes are encoded by nuclear DNA
(54/56).
It has been proposed that mitochondrial genomic
mutations may be a major cause of human diseases. In
1959, the first patient with a mtDNA deletion as a
cause of their illness was reported by Ernster. Luft is
often credited with recognizing the importance of
mitochondrial medicine in 1962. Mitochondrial muta-
tions and subsequent cytoplasmic segregation contri-
bute to neuromuscular disorders such as Kearns/
Sayre/chronic external ophthalmoplegia plus syn-
drome (57/60), mitochondrial encephalomyopathy,
lactic acidosis, and stroke-like episodes (MELAS)
(61), subacute necrotizing encephalomyopathies
(SNE, Leigh syndrome), progressive neuronal degen-
eration of childhood (Alpers syndrome) (59), and
myoclonic epilepsy associated with ragged-red muscle
fibers (MERRF) (54, 62). Interestingly, up to 67% of
patients with mtDNA disorders also manifest sensor-
ineural hearing loss (63).
Mitochondrial DNA deletions with subsequent
segregation and enrichment of the deletions through-
out life are contributing factors in the aging process
(9, 64, 65). MtDNA deletions in the human heart are
age-dependent (9), and these mitochondrial mutations
accumulate progressively until death. Cells that accu-
mulate large numbers of mitochondrial mutations
become bioenergetically deficient. This compromised
energy state explains their important role in many
human diseases (57). MtDNA deletions accumulate
preferentially in post-mitotic tissues such as the inner
ear, retina, skeletal muscle and brain. This appears to
account for the increased susceptibility of these tissues
to hypoxia, ischemia and aging. Richter has shown
that extensive oxidative damage occurs to mitochon-
drial and nuclear DNA, and has identified the
presence of 8-hydroxydeoxyguanosine (OH8dG) in
mtDNA and nuclear DNA (nDNA). This compound
is formed by excited oxygen species and is considered a
marker for DNA damage. Mitochondria treated with
prooxidants have an increased level of OH8dG. This
increased level may be caused by several factors,
including extensive oxygen metabolism, inefficient
DNA repair and lack of mitochondrial histones.
Studies have shown that increasing amounts of ROS
occur as a function of age, which lead to an increase in
membrane peroxide content and, thus, rapidly exceeds
the capacity of homeostatic protection (66). Thus,
there is extensive support that mtDNA deletions
accumulate with age and disease (67/69).
Deafness is clearly shown to have an association
with mtDNA mutations. It has been suggested that
mitochondrial diseases should be considered in cases
of progressive sensorineural hearing loss, especially
those associated with multisystem involvement (70,
71). A 10.4 kb mtDNA deletion has been identified in
association with maternally transmitted diabetes and
deafness, without ophthalmoplegia or mitochondrial
myopathies, which were the hallmark of mtDNA
deletion syndromes (72). Other studies have identified
mutations in the tRNA Leu(UUR) gene in a large
pedigree with maternally inherited diabetes mellitus
type II and deafness (73). A 3243 point mutation
(A0/G) has been demonstrated in a patient with
sensorineural deafness without diabetes (74). Several
human studies have demonstrated an association of
mitochondrial DNA mutations and presbyacusis,
including a study which demonstrated that older
patients with presbyacusis had a higher frequency of
the common aging deletion (4977 bp) compared with
similar aged patients without presbyacusis (75). It has
been demonstrated, using human archival temporal
bones, that 14 of 17 aged patients with presbyacusis
had the 4977 bp deletion compared with 8 of 17
control patients with normal hearing. This difference
was statistically significant (p B/0.05) (76).
Through experiments conducted in our laboratory,
various nutrient compounds have been identified that
enhance mitochondrial function by their ability to
protect and repair age-induced damage to cochlear
mtDNA (Fig. 3). One such compound is acetyl L-
carnitine. In one study involving Fischer rats, it was
noted that auditory thresholds actually improved over
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the course of 6 weeks, suggesting a strong positive role
for these compounds (77) (Fig. 4). In another study,
our laboratory investigated the effects of lecithin on
aging and age-associated hearing loss in rats by
measuring hearing sensitivities using auditory brain-
stem responses (ABR). In addition, mitochondrial
function, as a measure of aging, was assessed by
determining mitochondrial membrane potentials. This
was achieved using flow cytometry and by amplifying
mitochondrial DNA deletions associated with aging
using PCR. Harlan-Fischer rats, aged 18/20 months
(n/14), were divided into two groups. The experi-
mental group was supplemented orally for 6 months
with lecithin, a purified extract of soybean phospho-
lipid (Nutritional Therapeutics, Allendale, NJ, USA).
The data obtained were compared with the control
group. ABR were recorded at 2-month intervals and
showed significant preservation of hearing sensitivities
in the treated subjects. Flow cytometry revealed
mitochondrial membrane potentials to be significantly
higher in the treated subjects, suggesting preserved
mitochondrial function. Finally, the common aging
mitochondrial DNA deletion (mtDNA4834) were am-
plified from brain and cochlear tissue, including stria
vascularis and auditory nerve. This specific deletion
was quantitatively found to be fewer in all tissues in
the treated group compared with the controls. Based
on these findings, these experiments support our
hypothesis and provide evidence that lecithin may
preserve cochlear mitochondrial function and protect
from hearing loss associated with aging.
Caloric restriction has also been shown to retard the
aging process. In a study conducted by Lee et al. (78),
a control and calorie-restricted group of mice were
compared over a 30-month period, and the results
revealed that age-related changes in gene expression
profiles were remarkably attenuated by caloric restric-
tion. During aging there is a lower expression of
metabolic and biosynthetic genes, and caloric restric-
tion was noted to decrease the normal age-induced
genetic alterations by causing a metabolic shift toward
increased protein turnover and decreased macromole-
Fig. 3. (A) Data for the identification of ND1-16S rRNA
from stria vascularis. This represents a 601 bp product and
verifies the integrity of the PCR and the presence of
mitochondrial DNA. Lane 1: negative control; lane 2:
placebo; lane 3: diet restriction; lane 4: vitamin C; lane 5:
vitamin E; lane 6: melatonin; lane 7: lazaroid; lane 8:
molecular weight standards. (B) Data identifying the 4834
bp deletion (common aging deletion) from stria vascularis.
This represents a 597 bp product. Lane 1: negative control;
lane 2: placebo; lane 3: diet restriction; lane 4: vitamin C;
lane 5: vitamin E; lane 6: melatonin; lane 7: lazaroid; lane 8:
molecular weight standards. The DNA concentration was
normalized to 150 ng for all samples.
Fig. 4. Auditory threshold measurements in (A) placebo and (B) diet-restricted groups. Over the lifespan of 24/27 months, the
thresholds shifted the least in diet-restricted groups. The difference between diet-restricted groups and placebo was statistically
significant (pB/0.01).
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cular damage, hence creating a more bioenergetically
efficient cell. Another study by Lee et al. (79)
demonstrated that caloric-restricted mice produced
fewer proteins associated with the oxidative stress
response and heat shock factors.
DISCUSSION
Presbyacusis, or the progressive deterioration of hear-
ing associated with aging, is the most common cause
of adult auditory deficiency in the USA. This condi-
tion creates a significant burden not only for the
sufferers, but also for those who communicate with
them. The medical and socioeconomic costs are
staggering, and with the expansion of the world
population and the numbers of elderly individuals
expecting to more than double by the year 2030, this
problem is escalating. However, significant progress
has been made to identify the molecular mechanisms
of age-related hearing loss, and this in turn has led to
research on methods of mitigating the adverse effects
on the auditory system. Among the various mechan-
isms that are postulated to result in age-related
hearing loss in the current literature, the one that is
arguably the most intriguing, is the membrane hypoth-
esis of aging (MHA). Also known as the mitochon-
drial clock theory of aging, the premise of this theory
is that with aging, hypoperfusion of the cochlear tissue
occurs, which leads to ischemia and the formation of
ROS. These species are highly toxic substances that
adversely affect the auditory neuroepithelia. More
specifically, these ROS damage mitochondrial DNA
(mtDNA), resulting in both the production of specific
mtDNA deletions, as well as reducing the mitochon-
drial membrane potential (MMP). The resultant effect
is to render the mitochondria bioenergetically ineffi-
cient. These specific mtDNA deletions are also known
as the common aging deletion. Studies are increasingly
supportive of this relationship between presbyacusis
and the common aging deletion.
The results of these studies have further led to
investigations concerning the role of antioxidants,
nutritional supplementation, and dietary restriction
on hearing loss and the aging process in general
There is compelling evidence to suggest that the
beneficial effect of these compounds is to slow down
the ‘mitochondrial clock’, by decreasing the amount
of mtDNA deletions and causing less of a reduction in
mitochondrial membrane potential. Currently, our
laboratory is investigating the role of resveratrol, a
constituent of the red wine grape, in attenuating the
age-induced reductions in auditory sensitivity; specifi-
cally, its antioxidant effect on the mitochondrial
apparatus. This study will hopefully provide strong
empirical evidence of an integrated hypothesis of
aging and presbyacusis, with the ultimate goal of
enhancing our understanding of the mechanisms that
surround senescence, both as a phenomenon and as an
intrinsic biological property.
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